Vencefta T 250mg/31.25mg Injection
Marketer
Vokin Biotech Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Vencefta T 250mg/31.25mg Injection
Combifenta, a 250mg/31.25mg injectable combination drug, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be under a physician's direction; adherence to the prescribed schedule is crucial. Complete the full course, regardless of symptom improvement, as premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration promote recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Vencefta T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Vencefta T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Vencefta T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Vencefta T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vencefta T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Vencefta T 250mg/31.25mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactum). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Vencefta T 250mg/31.25mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
Employing Vencefta T 250mg/31.25mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Vencefta T 250mg/31.25mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Vencefta T 250mg/31.25mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Vencefta T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The administration of Vencefta T 250mg/31.25mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dose of Vencefta T 250mg/31.25mg Injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Vencefta T 250mg/31.25mg Injection :
Should you forget a scheduled Vencefta T 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Vencefta T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently